Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SRDX save search
Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
Published: 2023-02-06 (Crawled : 01:00) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
year financial
Surmodics to Host Virtual Annual Meeting of Shareholders - January 31, 2023
Published: 2023-01-31 (Crawled : 14:20) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
| Email alert
Add to watchlist
meeting
Surmodics to Report First Quarter of Fiscal 2023 Financial Results on February 6
Published: 2023-01-26 (Crawled : 15:00) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: 2.14%
H: 1.09%
C: -1.24%
report financial results
Pomerantz Law Firm Announces the Filing of a Class Action Against Gemini Trust Company, LLC and Certain Officers
Published: 2023-01-25 (Crawled : 03:00) - prnewswire.com
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -2.68%
H: 0.0%
C: 0.0%
trust
Pomerantz Law Firm Investigates Claims on Behalf of Apple iPhone 7 Owners who Suffered Performance Degradation Following a Device Update
Published: 2023-01-24 (Crawled : 05:00) - prnewswire.com
FSM | $3.615 -0.14% 1.8M
|
Non-Energy Minerals
|
| O: 2.15%
H: 0.0%
C: 0.0%
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: 7.15%
H: 0.0%
C: 0.0%
device apple update
Ritchie Bros. Announces $500 Million Strategic Investment from Starboard Value
Published: 2023-01-23 (Crawled : 12:20) - prnewswire.com
RBA | $62.79 1.27% 810K
|
Commercial Services
|
| O: 3.85%
H: 0.89%
C: -0.34%
RGS | $1.55 -6.06% 170K
|
Consumer Services
|
| O: 3.7%
H: 11.43%
C: 7.86%
PRGO | $36.17 -0.9% 420K
|
Health Technology
|
| O: -0.4%
H: 2.22%
C: 1.89%
IAA F | $42.9 1.25% 1.1M
|
Retail Trade
|
| O: 7.47%
H: 2.64%
C: 0.7%
DRI | $148.61 -0.66% 270K
|
Consumer Services
|
| O: 1.1%
H: 0.4%
C: 0.16%
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -4.57%
H: 0.0%
C: 0.0%
QMCO A | $1.515 -2.26% 72K
|
Electronic Technology
|
| O: 3.45%
H: 0.0%
C: -0.61%
Global In-Vitro Diagnostics (IVD) Market Report 2022: Sector to Reach $144.7 Billion by 2027 at a 4.6% CAGR
Published: 2023-01-22 (Crawled : 00:00) - prnewswire.com
QGEN | $49.62 -0.36% 560K
|
Health Technology
|
| O: 0.6%
H: 0.69%
C: 0.26%
DHR | News A | $263.47 -0.95% 970K
|
Health Technology
|
| O: 0.63%
H: 1.96%
C: 1.11%
BIO | News | $472.39 -0.95% 29K
|
Health Technology
|
| O: 0.62%
H: 2.76%
C: 2.1%
BDX | News S | $250.35 -1.12% 370K
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: -1.6%
A | News | $154.35 -0.1% 240K
|
Health Technology
|
| O: 1.71%
H: 2.3%
C: 1.96%
ABT | News | $110.32 -1.49% 1.5M
|
Health Technology
|
| O: 0.08%
H: 2.02%
C: 1.41%
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -4.57%
H: 0.0%
C: 0.0%
QDEL M | $88.075 -2.13% 120K
|
Health Technology
|
| O: 1.96%
H: 3.1%
C: 3.09%
QGEN | $49.62 -0.36% 560K
|
Health Technology
|
| O: 0.6%
H: 0.69%
C: 0.26%
ILMN | News | $202.53 -6.12% 1.4M
|
Health Technology
|
| O: 4.44%
H: 5.78%
C: 5.53%
HOLX | $86.02 -0.16% 680K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: 2.43%
CEMI | $0.4404 -0.02% 330K
|
Health Technology
|
| O: 2.6%
H: 6.05%
C: 4.29%
AXDX M | $0.6775 0.64% 70K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
global report in-vitro diagnostics market
Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -21.19%
H: 0.0%
C: 0.0%
drug conference for platform
Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
Published: 2023-01-19 (Crawled : 13:00) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -21.19%
H: 0.0%
C: 0.0%
fda for application approval update
Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18
Published: 2023-01-16 (Crawled : 15:00) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
| Email alert
Add to watchlist
conference trial
Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium
Published: 2022-11-17 (Crawled : 14:20) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -4.45%
H: 0.81%
C: -1.17%
trial
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
Published: 2022-11-11 (Crawled : 14:00) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -0.78%
H: 0.0%
C: 0.0%
trial
Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance
Published: 2022-11-09 (Crawled : 13:00) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -5.03%
H: 0.21%
C: -4.67%
year financial
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
Published: 2022-11-02 (Crawled : 13:00) - biospace.com/
ABT | News | $110.32 -1.49% 1.5M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
conference trial transcend
First Round of Late-Breaking Clinical Trial Results Announced at VIVA22
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
viva22 trial results
Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th
Published: 2022-10-28 (Crawled : 16:00) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: 1.08%
H: 3.11%
C: 2.5%
report year financial results
Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
ABT | News | $110.32 -1.49% 1.5M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: 1.29%
H: 3.22%
C: 1.97%
trial transcend
6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe
Published: 2022-10-11 (Crawled : 13:00) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -1.64%
H: 3.43%
C: 1.64%
europe trial
6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe
Published: 2022-10-07 (Crawled : 16:00) - biospace.com/
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -1.74%
H: 1.8%
C: -3.22%
europe study
Next Generation Sequencing (NGS) Market is expected to generate a revenue of USD 49.76 Billion by 2030, Globally, at 20.82% CAGR: Verified Market Research®
Published: 2022-09-16 (Crawled : 14:20) - prnewswire.com
SRDX | $29.36 -5.87% 14K
|
Health Technology
|
| O: -0.75%
H: 7.1%
C: 2.22%
research expected market
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
DGLY | News | $5.43 1722.15% 160K
|
Electronic Technology
CELZ | $1.115 115.54% 120M
|
AVRO | $1.78 104.01% 11M
|
Health Technology
GFAI | $0.4936 44.54% 62M
|
KPRX | News | $6.43 41.32% 16M
|
Manufacturing
WETG | $0.551 34.39% 13M
|
PRFX | $0.65 30.0% 13M
|
Health Technology
BBLG | $0.3799 20.76% 740K
|
n/a
NEWR A | $77.25 19.62% 2.7M
|
Technology Services
THCH | $4.99 18.81% 560K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.